Blood Cancer Discovery · 2022 · 23 citations · 76 references
MedicineGeneticsOncologyEpigeneticsGene ExpressionTranscriptional RegulationB Cell BiologyEnhancer ArchitectureEnhancer FunctionB-cell Acute Lymphoblastic LeukemiaCell-type-specific EnhancersEnhancer MaintenanceEnhancer-mediated ExpressionEts Family Transcription FactorsGene Expression ProgrammingTumor Suppressor Gene AlterationsTumor Suppressor Gene Loss
Distal enhancers play critical roles in sustaining oncogenic gene-expression programs. We identify aberrant enhancer-like activation of GGAA tandem repeats as a characteristic feature of B-cell acute lymphoblastic leukemia (B-ALL) with genetic defects of the ETV6 transcriptional repressor, including ETV6-RUNX1+ and ETV6-null B-ALL. We show that GGAA repeat enhancers are direct activators of previously identified ETV6-RUNX1+/- like B-ALL "signature" genes, including the likely leukemogenic driver EPOR. When restored to ETV6-deficient B-ALL cells, ETV6 directly binds to GGAA repeat enhancers, represses their acetylation, downregulates adjacent genes, and inhibits B-ALL growth. In ETV6-deficient B-ALL cells, we find that the ETS transcription factor ERG directly binds to GGAA microsatellite enhancers and is required for sustained activation of repeat enhancer-activated genes. Together, our findings reveal an epigenetic gatekeeper function of the ETV6 tumor suppressor gene and establish microsatellite enhancers as a key mechanism underlying the unique gene-expression program of ETV6-RUNX1+/- like B-ALL. SIGNIFICANCE: We find a unifying mechanism underlying a leukemia subtype-defining gene-expression signature that relies on repetitive elements with poor conservation between humans and rodents. The ability of ETV6 to antagonize promiscuous, nonphysiologic ERG activity may shed light on other roles of these key regulators in hematolymphoid development and human disease. See related commentary by Mercher, p. 2. This article is highlighted in the In This Issue feature, p. 1.
76
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
Kathryn G. Roberts, Yongjin Li, Debbie Payne-Turner et al. · New England Journal of Medicine · 2014 · 1.4K citations · Full text
Life Sciences, Genetics, Oncology +17
The chromatin accessibility landscape of primary human cancers
M. Ryan Corces, Jeffrey M. Granja, Shadi Shams et al. · Science · 2018 · 1.3K citations · Full text
Optimized libraries for CRISPR-Cas9 genetic screens with multiple modalities
Kendall R Sanson, Ruth E. Hanna, Mudra Hegde et al. · Nature Communications · 2018 · 1.1K citations · Full text
Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours
Xiaotu Ma, Yu Liu, Yanling Liu et al. · Nature · 2018 · 945 citations · Full text
Life Sciences, Genetics, Oncology +17